Cargando…

EPEN-11. TUMOR DIFFERENTIATION IMPACTS THE BIOLOGY OF RECURRENCE IN CHILDHOOD POSTERIOR FOSSA EPENDYMOMA

Ependymoma (EPN) of childhood is curable in only 50% of cases, with recurrences in the remainder that are refractory to treatment. In recent years significant advances have been made in understanding the molecular and cellular biology of EPN. Recent studies show that PFA subgroup EPN are comprised o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donson, Andrew, Ritzmann, Timothy, Willard, Nicholas, Griesinger, Andrea, Amani, Vladimir, Harris, Faith, Grimaldo, Enrique, Sanford, Bridget, Riemondy, Kent, Hankinson, Todd, Grundy, Richard, Foreman, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Ependymoma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168184/ http://dx.doi.org/10.1093/neuonc/noab090.061

Ejemplares similares

EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA
por: Willard, Nicholas, et al.
Publicado: (2021)

EPEN-07. SINGLE-CELL RNA SEQUENCING IDENTIFIES A UNIQUE MYELOID SUBPOPULATION ASSOCIATED WITH MESENCHYMAL TUMOR SUBPOPULATION IN POOR OUTCOME PEDIATRIC EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2021)

EPEN-26. NON-CANONICAL NF-κB SIGNALING DRIVES MESENCHYMAL EPENDYMAL CELL SUBPOPULATION IN PFA EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2020)

EPEN-16. Epithelial Progenitor Cell Abundance and Copy Number Variant Gains and Losses Impact the Biology of Recurrent Ependymoma
por: Norris, Gregory, et al.
Publicado: (2022)

EPEN-31. SINGLE-CELL RNAseq OF CHILDHOOD EPENDYMOMA REVEALS DISTINCT NEOPLASTIC CELL SUBPOPULATIONS THAT IMPACT ETIOLOGY, MOLECULAR CLASSIFICATION AND OUTCOME
por: Donson, Andrew, et al.
Publicado: (2020)

EPEN-07. A MULTICENTER STUDY OF POOR PROGNOSIS CHROMOSOME 1Q GAIN AND/OR 6Q LOSS IN POSTERIOR FOSSA A EPENDYMOMA SHOWS INCREASED PREVALENCE FROM 20% AT DIAGNOSIS TO 60% AT FIRST RECURRENCE
por: Donson, Andrew, et al.
Publicado: (2023)

EPEN-23. A COMPUTATIONAL ANALYSIS OF THE TUMOUR IMMUNE MICROENVIRONMENT IN PAEDIATRIC EPENDYMOMA
por: Ritzmann, Timothy, et al.
Publicado: (2020)

EPEN-22. SINGLE-CELL RNA SEQUENCING IDENTIFIES UPREGULATION OF IKZF1 IN PFA2 MYELOID SUBPOPULATION DRIVING AN ANTI-TUMOR PHENOTYPE
por: Griesinger, Andrea, et al.
Publicado: (2020)

EPEN-26. Chemokine receptor blockade reverses CCL2 mediated immunosuppression and restores CAR-T cell function in posterior fossa ependymoma
por: Cole, Allison P, et al.
Publicado: (2022)

EPEN-30. 5FU with Radiation Followed by Maintenance of 5FU and ATRA Significantly Improves Survival of 1q+/6q- PFA Ependymoma Xenograft Models
por: Grimaldo, Enrique, et al.
Publicado: (2022)

EPEN-08. COMBINED PDGFR INHIBITOR AXITINIB AND RETINOID TRETINOIN DECREASES PROLIFERATION AND HIGH-RISK NEOPLASTIC SUBPOPULATION PROPORTIONS PFA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2023)

EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022)

EPEN-06. CELL ECOSYSTEM AND SIGNALING PATHWAYS OF PRIMARY AND METASTATIC PEDIATRIC POSTERIOR FOSSA EPENDYMOMA
por: Aubin, Rachael, et al.
Publicado: (2021)

EPEN-10. UNRAVELLING THE TUMOR IMMUNE MICROENVIRONMENT OF POSTERIOR FOSSA A EPENDYMOMAS ON RNA AND PROTEIN EXPRESSION LEVELS
por: F. Feenstra, Fenna, et al.
Publicado: (2021)

EPEN-11. ONGOING RESPONSE IN A MULTIPLY RELAPSED METASTATIC POSTERIOR FOSSA EPENDYMOMA A AFTER VORINOSTAT AND CONCOMITANT IRRADIATION
por: Gorsi, Hamza S, et al.
Publicado: (2020)

EPEN-01. MULTIDISCIPLINARY TREATMENT IN EPENDYMOMA
por: Hirokawa, Daisuke
Publicado: (2020)

EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)

EPEN-42. MOLECULAR PROFILING REVEALS DISTINCT SUBGROUPS OF PEDIATRIC SPINAL EPENDYMOMA
por: Ahmad, Omar, et al.
Publicado: (2020)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

EPEN-20. EZHIP/CATACOMB COOPERATES WITH PDGF-A AND p53 LOSS TO GENERATE A GENETICALLY ENGINEERED MOUSE MODEL FOR POSTERIOR FOSSA A EPENDYMOMA
por: Kagan, Emily, et al.
Publicado: (2020)

EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020)

EPEN-13. PATTERN OF RELAPSE IN POSTERIOR FOSSA EPENDYMOMA GROUP A
por: Bajin, Inci Yaman, et al.
Publicado: (2023)

EPEN-16. TRANSCRIPTIONAL REGULATORY CIRCUITRIES AS MOLECULAR TARGETS IN EPENDYMOMA
por: Bertrand, Kelsey, et al.
Publicado: (2020)

EPEN-35. PERITONEAL CARCINOMATOSIS OF ANAPLASTIC EPENDYMOMA: FIRST REPORTED CASE
por: Schwartz, Jonathan, et al.
Publicado: (2020)

EPEN-52. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA
por: Kumar, Sachin, et al.
Publicado: (2020)

EPEN-37. TREATMENT OUTCOME OF RECURRENT EPENDYMOMA IN CHILDREN IN NORTHERN EGYPT
por: Fadel, Shady, et al.
Publicado: (2020)

EPEN-45. NORMALIZING AND FACILITATING GENOMIC TESTING AT DIAGNOSIS IN PEDIATRIC EPENDYMOMA
por: Pickle, Emily Owens, et al.
Publicado: (2020)

EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways
por: Maass, Kendra K, et al.
Publicado: (2022)

EPEN-31. Developmental and Oncogenic Transcription Factor Circuits as Dependencies in Ependymoma
por: Mack, Stephen
Publicado: (2022)

EPEN-07. PATTERNS OF EXTRANEURAL METASTASES IN PEDIATRIC SUPRATENTORIAL EPENDYMOMA: CASE SERIES AND REVIEW OF THE LITERATURE
por: Chan, Priya P, et al.
Publicado: (2020)

EPEN-03. LONG-TERM FOLLOW-UP OF AIEOP 2ND SERIES OF CHILDREN AND ADOLESCENT WITH PRIMARY INTRACRANIAL (ST:SUPRATENTORIAL; PF: POSTERIOR FOSSA) EPENDYMOMA AND METHYLATION GROUPS RE-ANALYSES
por: Massimino, Maura, et al.
Publicado: (2020)

EPEN-51. CHILDHOOD INTRACRANIAL EPENDYMOMA: A MULTI-CENTER RETROSPECTIVE ANALYSIS
por: Pickle, Emily Owens, et al.
Publicado: (2020)

EPEN-32. Leveraging cell surface targets as therapeutic vulnerabilities for pediatric ependymoma
por: Bertrand, Kelsey
Publicado: (2022)

EPEN-25. A novel spontaneous model of ZFTA-RELA fusion ependymoma
por: Bell, Sigourney, et al.
Publicado: (2022)

EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY
por: A. Ritzmann, Timothy, et al.
Publicado: (2021)

EPEN-43. TARGETING INTRA-TUMOUR HETEROGENEITY IN PAEDIATRIC EPENDYMOMA: AN INTEGRATED OMICS STUDY TOWARDS PATIENT-TAILORED THERAPY
por: Pandele, Alina, et al.
Publicado: (2020)

EPEN-54. ACNS0831, PHASE III RANDOMIZED TRIAL OF POST-RADIATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPENDYMOMA AGES 1 TO 21 YEARS
por: Smith, Amy, et al.
Publicado: (2020)

EPEN-06. CHEMOTHERAPY OF RECURRENT EPENDYMOMA: LONG-TERM RESPONSE ONLY IN FEW CASES
por: Adolph, Jonas, et al.
Publicado: (2020)

EPEN-04. Refinement of molecular and clinical characteristics in a cohort of 1,801 ependymomas
por: Pohl, Lara, et al.
Publicado: (2022)

EPEN-23. Interaction of epigenetic regulation and telomerase re-activation in high-risk ependymoma
por: Jaunecker, Carola N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rrbnccdf3hjnr9n6hrnufr45hu